Ocular Hypertension: all 659 studies

Page 6 of 7. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• Efficacy Comparison of Xalatan and Azopt on POAG and OHStatus unknownNCT01084902Not applicable
• The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous EyesCompletedNCT01067482
• Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01060579Phase 2
• A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGCompletedNCT01037036Phase 2
• Use of an Ocular Telemetry Sensor in Diamox Treated PatientsCompletedNCT01028664Not applicable
• Tolerance and Effect on Intraocular Pressure After Administration of SYL040012CompletedNCT00990743Phase 1
• A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension PatientsCompletedNCT00972426Phase 4
• A Study of Different Formulations of the L-PPDS in Subjects With OH or OAGCompletedNCT00967811Phase 2
• Central Corneal Thickness and 24-hour Fluctuation of Intraocular PressureCompletedNCT00941525Phase 4
• Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed CombinationCompletedNCT00941096Phase 4
• Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00928590Phase 3
• DuoTrav APS Versus XALACOM® in Ocular Surface HealthTerminatedNCT00912054Phase 3
• Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular PressureCompletedNCT00906594Phase 4
• A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)CompletedNCT00902200Phase 2
• Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface HealthCompletedNCT00892762Phase 3
• A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle GlaucomaCompletedNCT00887029Phase 4
• Equivalence Study of Dorzolamide 2% Eye Drops SolutionCompletedNCT00878917Phase 3
• Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00872651Phase 3
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionCompletedNCT00868894Phase 1/2
• Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabCompletedNCT00864838Phase 2
• Safety and Efficacy Study of DuoTrav APS Versus DuoTravWithdrawnNCT00862472Phase 3
• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsCompletedNCT00856622Phase 3
• A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle GlaucomaWithdrawnNCT00855517Phase 2
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular HypertensionCompletedNCT00846989Phase 1/2
• Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT00845299Phase 2
• Evaluation of Pascal Laser TrabeculoplatyCompletedNCT00838721Not applicable
• DuoTrav® Eye Drops As Replacement Therapy ProgramCompletedNCT00828906Phase 4
• An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular HypertensionCompletedNCT00825396Not applicable
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822081Phase 4
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822055Phase 4
• A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)CompletedNCT00821002Phase 2
• A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle GlaucomaCompletedNCT00820300Phase 2
• The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)WithdrawnNCT00815373Not applicable
• The International Collaborative Exfoliation Syndrome Treatment StudyStatus unknownNCT00804115Not applicable
• Ocular Hypertension Treatment Study (OHTS)CompletedNCT00803998
• Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without PreservativeCompletedNCT00803387
• Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.CompletedNCT00801437
• A Study of Glaucoma or Ocular Hypertension in Patients Within the United StatesCompletedNCT00800267Phase 3
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®CompletedNCT00799682Phase 4
• A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular HypertensionTerminatedNCT00788541Phase 2
• Intraocular Pressure With Loteprednol and DexamethasoneCompletedNCT00781300Phase 4
• Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPTTerminatedNCT00767494Phase 3
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPTTerminatedNCT00767481Phase 3
• Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT00761995Phase 4
• Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00761709Phase 2
• Safety and Efficacy of Travoprost/Timolol BAC-freeCompletedNCT00760539Phase 3
• Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00759239Phase 4
• Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT00753168Phase 1/2
• A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT00751127Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaCompletedNCT00751062Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomCompletedNCT00751049Phase 3
• IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical SteroidsStatus unknownNCT00744666Phase 4
• Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT00706927Not applicable
• Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)CompletedNCT00698945Phase 4
• Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00691717Phase 2/3
• Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)CompletedNCT00691639
• Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular PressureCompletedNCT00683501Phase 1/2
• Glaucoma Adherence Study, SpainCompletedNCT00680329
• Glaucoma Adherence StudyCompletedNCT00676637
• Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin AnalogsCompletedNCT00675207Phase 4
• A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00672997Phase 3
• Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00670033Phase 2
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00657579Phase 2
• To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00656240Phase 2
• Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular HypertensionCompletedNCT00652496Phase 2
• Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNCT00652483Phase 3
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNCT00652106Phase 3
• Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00651859Phase 2
• Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsCompletedNCT00651612Phase 3
• Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00650702Phase 2
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionCompletedNCT00650338Phase 2
• A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle GlaucomaCompletedNCT00647101Phase 4
• A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.CompletedNCT00638742Phase 1
• Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose TravoprostCompletedNCT00637130Phase 2
• A Investigator Masked Parallel Comparison of Tolerability of Combigan and CosoptCompletedNCT00621335
• Adjunctive Study of AL-37807 Ophthalmic SuspensionCompletedNCT00620256Phase 2
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye DropsCompletedNCT00596791Phase 3
• Patient Preference StudyCompletedNCT00576342Phase 3
• Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser TrabeculoplastyStatus unknownNCT00567411Not applicable
• A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)CompletedNCT00546286Phase 3
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527501Phase 2
• Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT00515424Phase 1
• Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular HypertensionCompletedNCT00503360Phase 1
• Early Diagnosis, Pathogenesis and Progression of Open Angle GlaucomaStatus unknownNCT00494923
• Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early GlaucomaStatus unknownNCT00476138Phase 1/2
• A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular HypertensionCompletedNCT00465803Phase 3
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00465621Phase 2
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or GlaucomaCompletedNCT00443924Phase 1
• Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%CompletedNCT00440141Phase 4
• Neurovascular Coupling in Eyes of Glaucoma PatientsCompletedNCT00430209
• Neurovascular Coupling in Eyes of Glaucoma PatientsCompletedNCT00429819
• Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma ProgressionCompletedNCT00424996
• Intraocular Pressure Accuracy and Variability of the Barraquer TonometerStatus unknownNCT00409669Not applicable
• Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma DropsCompletedNCT00402493Not applicable
• A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00372931Phase 2
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00372827Phase 4
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular HypertensionCompletedNCT00348062Phase 4
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionCompletedNCT00348023Phase 4
• The Efficacy of Selective Laser TrabeculoplastyStatus unknownNCT00347893

← Ocular Hypertension overview